Metformin alleviates reactive gliosis and neurodegeneration, improving cognitive deficit in a rat model of temporal lobe epilepsy
Authors:
Open Access
- 10 August 2024
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 1844, 149138
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology, Ministry of Science and Technology, India
- Council of Scientific and Industrial Research, India
This publication has 40 references indexed in Scilit:
- AMPK role in epilepsy: a promising therapeutic target?Journal of Neurology, 2023
- Implications of BCRP modulation on PTZ-induced seizures in mice: Role of ko143 and metformin as adjuvants to lamotrigineNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Long-term use of metformin and Alzheimer’s disease: beneficial or detrimental effectsInflammopharmacology, 2023
- PERK inhibitor, GSK2606414, ameliorates neuropathological damage, memory and motor functional impairments in cerebral ischemia via PERK/p-eIF2ɑ/ATF4/CHOP signalingMetabolic Brain Disease, 2023
- Neuroinflammatory mediators in acquired epilepsy: an updateInflammation Research, 2023
- Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer’s diseaseNaunyn-Schmiedeberg's Archives of Pharmacology, 2021
- Metformin ameliorates the status epilepticus- induced hippocampal pathology through possible mTOR modulationInflammopharmacology, 2021
- Factors for cognitive impairment in adult epileptic patientsBrain and Behavior, 2019
- Metformin Plus Caloric Restriction Show Anti-epileptic Effects Mediated by mTOR Pathway InhibitionCellular and Molecular Neurobiology, 2018
- Evaluation of metformin effects in the chronic phase of spontaneous seizures in pilocarpine model of temporal lobe epilepsyMetabolic Brain Disease, 2017